New China Life Insurance Co (STU:NCL) Research & Development: €0 Mil (TTM As of Mar. 2026)


STU:NCL New China Life Insurance Co Ltd STU:NCL
64 GF Score
Price €5.10
GF Value €4.38
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is New China Life Insurance Co Research & Development?

New China Life Insurance Co STU:NCL -1.80% 64 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates STU:NCL with a GF Score™ of 64/100 and a GF Value™ of €4.38 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. New China Life Insurance Co's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

New China Life Insurance Co  (STU:NCL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

New China Life Insurance Co Research & Development Related Terms

New China Life Insurance Co Research & Development Historical Data

* Premium members only.

The historical data trend for New China Life Insurance Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New China Life Insurance Co Research & Development Chart

New China Life Insurance Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

New China Life Insurance Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:NCL
64GF Score
New China Life Insurance Co Ltd STU:NCL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

New China Life Insurance Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
New China Life Insurance Co (STU:NCL) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on New China Life Insurance Co and its competitors.
Is New China Life Insurance Co's Research & Development too high?
New China Life Insurance Co's current Research & Development is €0 Mil. Overall, New China Life Insurance Co has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does New China Life Insurance Co's Research & Development compare to AFL and MET?
New China Life Insurance Co's Research & Development of €0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on New China Life Insurance Co and its competitors. New China Life Insurance Co's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New China Life Insurance Co stock overvalued right now?
Based on GuruFocus' analysis, New China Life Insurance Co (STU:NCL) is currently considered Modestly Overvalued. The stock's GF Value™ is €4.38, compared to a current price of €5.10 — trading 16.4% above its estimated fair value. The current Research & Development is €0 Mil. New China Life Insurance Co's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For New China Life Insurance Co (STU:NCL), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is New China Life Insurance Co (STU:NCL) Overvalued in 2026?

Based on GuruFocus' analysis, New China Life Insurance Co stock appears to be overvalued. The current stock price of €5.10 is trading 16.4% above its estimated GF Value™ of €4.38. GuruFocus considers New China Life Insurance Co to be Modestly Overvalued.

Key valuation signals for STU:NCL:

  • Research & Development: €0 Mil
  • GF Value™: €4.38 vs. price of €5.10 (16.4% above fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the STU:NCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

New China Life Insurance Co Business Description

Address A12 Jianguomenwai Avenue, New China Insurance Tower, Chaoyang District, Beijing, CHN, 100022
New China Life Insurance Co Ltd is headquartered in Beijing and was established in 1996 by a combination of state-owned enterprises and private firms. It is currently the fourth-largest life insurer in China based on total assets. New China Life offers a wide range of life insurance products and services to both individual and institutional customers through its extensive distribution networks and diverse marketing channels. Additionally, it manages and invests insurance funds through its subsidiaries, including its Asset Management Company and Asset Management Company (Hong Kong).
64GF Score

Get the complete analysis for STU:NCL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.10
Price
€4.38
GF Value